Developments in Blood-Brain Barrier Penetrance and Drug Repurposing for Improved Treatment of Glioblastoma
Glioblastoma (GBM) is one of the most common, deadly, and difficult-to-treat adult brain tumors. Surgical removal of the tumor, followed by radiotherapy (RT) and temozolomide (TMZ) administration, is the current treatment modality, but this regimen only modestly improves overall patient survival. In...
Main Authors: | Bryan G. Harder, Mylan R. Blomquist, Junwen Wang, Anthony J. Kim, Graeme F. Woodworth, Jeffrey A. Winkles, Joseph C. Loftus, Nhan L. Tran |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-10-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fonc.2018.00462/full |
Similar Items
-
An Alternative Pipeline for Glioblastoma Therapeutics: A Systematic Review of Drug Repurposing in Glioblastoma
by: Seán B. Lyne, et al.
Published: (2021-04-01) -
Q-Cell Glioblastoma Resource: Proteomics Analysis Reveals Unique Cell-States Are Maintained in 3D Culture
by: Rochelle C. J. D’Souza, et al.
Published: (2020-01-01) -
Inhibition of Carbonic Anhydrase 2 Overcomes Temozolomide Resistance in Glioblastoma Cells
by: Kai Zhao, et al.
Published: (2021-12-01) -
Radiogenomic Predictors of Recurrence in Glioblastoma—A Systematic Review
by: Felix Corr, et al.
Published: (2022-03-01) -
Atypical clinical presentation of glioblastoma mimicking autoimmune meningitis in an adult
by: Angelika Stapińska-Syniec, et al.
Published: (2022-06-01)